Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA)

Clinical trial NCT05943223 · COMPLETED

Trial details

NCT number: NCT05943223
Sponsor: McMaster Children's Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Appendicitis Perforated

Start date: 2024-09-09
Primary completion: 2025-07-16
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.